Recruiting

CARE for CD

Sponsor:

University of Colorado, Denver

Code:

NCT06949813

Conditions

Anxiety in Pregnancy

Mood Disorder Due to Specified Medical Condition

Eligibility Criteria

Sex: Female

Age: 0+

Healthy Volunteers: Not accepted

Interventions

BE-OR: Brief Intervention to the Operating Room

Interaction: Facetime with Clinical Provider

Study Details

Brief summary:

Perinatal mental health disorders are the most prevalent perinatal comorbidity and are associated with the primary cause of maternal mortality in the United States (US) - suicide. Diagnosis of a high-risk pregnancy and cesarean delivery (CD) are both associated with increased risk for perinatal mood, anxiety, and trauma symptoms (PMATS). There is a deficit in resources and access to mental health treatment for pregnant patients, with some treatments being cost-prohibitive and requiring multiple sessions. Additionally, current approaches to addressing PMATS are reactive rather than preventive. There is evidence in the non-obstetric population that single-session cognitive behavioral therapy interventions targeting anxiety sensitivity (fear of fear) can prevent the development of anxiety and trauma symptoms when individuals are exposed to trauma. The investigators developed a low-cost, 1-hour, single-session prevention intervention that included psychoeducation about anxiety sensitivity, coupled with a brief exposure to the operating room environment and CD procedures. To revise the implementation plan and intervention (CARE: Communication, Agency, Readiness, Empowerment for cesarean delivery \[CD\]) for use in large L\&D units with a broader population of patients, a fully powered multisite randomized control trial (RCT) is needed. Before initiating such a trial, work needs to be done to modify the intervention and implementation through a process of iterative refinement to enhance the acceptability, appropriateness, and feasibility of implementation in L\&D units across the country, as well as its efficacy at engaging with the target mechanism (anxiety sensitivity). Using a logic model to guide the iterative refinement process through fast feedback loops and an atmosphere of co-creation, study investigators will gather critical input from stakeholders (individuals with lived experiences, community partners, front-line clinicians, and hospital staff) via 12 workgroups, 12 user-testing design sessions, and repeated engagement with a steering council. Following this refinement process, a treatment development pilot RCT at a large L\&D unit will assess the efficacy of CARE for CD by probing engagement with the target mechanism, as well as assess the feasibility of implementation. Finally, the updated logic model and pilot trial results will inform the development of a protocol for a multisite RCT through engagement with expert consultants in a community engagement studio and further feedback from the steering council.

Conditions

Anxiety in Pregnancy

Mood Disorder Due to Specified Medical Condition

Study ID

NCT06949813

Start date

Oct 13, 2025

Status verified date

Mar, 2026

Completion date

Apr 30, 2027

Anticipated

Primary completion date

Apr 30, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: Female

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Pregnant Patients at 22-37 weeks gestation
  • Single or multiple gestation
  • Nulliparous or multiparous (with prior vaginal or cesarean delivery)
  • Antepartum admission for at least 3 days
  • High-risk pregnancy due to maternal/fetal comorbidities
  • Anticipated cesarean delivery at the University of Colorado

Exclusion Criteria:

  • Lack of capacity to consent
  • Medical factors prohibiting participation in the intervention as determined by the inpatient obstetric medical team.
  • Anticipated cesarean within 7 days of enrollment

Study Design

Enrollment

80 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Prevention

Interventions and Outcome Measures

Arms

experimental: Intervention

Intervention: (N= 40) Participants will be scheduled to receive the 1-hour, single-session CARE intervention administered by a medical and mental health provider trained in the intervention. CARE will consist of psychoeducation and brief immersive exposure to the operating room.

experimental: Interaction Control

Interaction Control: (N = 20) Participants will receive a 1-hour, single-session meeting with a nurse educator that will occur within a single patient room on L\&D. This condition will provide the same front-line clinician facetime as the treatment condition but will not include the clinical content of the intervention (psychoeducation + exposure).

no intervention: Care as Usual

Care as Usual Control: (N = 20) Participants will receive all the standard prenatal and CD education. The participants will not receive any additional face-to-face interaction with front-line clinicians as part of the study.

Interventions

BE-OR: Brief Intervention to the Operating Room

See intervention group section for details

Interaction: Facetime with Clinical Provider

See Interaction group section for details

Primary outcome measure

  • Anxiety-sensitivity Index 3 [ Time Frame: Baseline ]
  • Anxiety-sensitivity Index 3 [ Time Frame: Approximately 3 days (range=1-5) after intervention (CARE and interaction control conditions) or approximately 5 days (range = 3-7) after enrollment (care as usual condition) ]

Central Contacts and Locations

Locations

University of Colorado Hospital

Recruiting

Aurora, Colorado, United States, 80045

Contacts

Principal Investigator:

Cristina L Wood, MD

More Information

Sponsor

University of Colorado, Denver

Last update posted

Mar 23, 2026

Last verified

Mar, 2026

Keywords

  • perinatal mood and anxiety disorders
  • cesarean delivery
  • Single session immersive intervention
  • Randomized Controlled Trial

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Colorado, Denver on 2026-03-23.